Amrutanjan Health Care Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Sambhu Sivalenka
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 25.8yrs |
| Eigendom CEO | 13.9% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 3.4yrs |
Recente managementupdates
Recent updates
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹426m |
| Mar 31 2024 | n/a | n/a | ₹450m |
| Dec 31 2023 | n/a | n/a | ₹440m |
| Sep 30 2023 | n/a | n/a | ₹373m |
| Jun 30 2023 | n/a | n/a | ₹432m |
| Mar 31 2023 | n/a | n/a | ₹398m |
| Dec 31 2022 | n/a | n/a | ₹418m |
| Sep 30 2022 | n/a | n/a | ₹517m |
| Jun 30 2022 | n/a | n/a | ₹588m |
| Mar 31 2022 | n/a | n/a | ₹672m |
| Dec 31 2021 | n/a | n/a | ₹627m |
| Sep 30 2021 | n/a | n/a | ₹631m |
| Jun 30 2021 | n/a | n/a | ₹668m |
| Mar 31 2021 | n/a | n/a | ₹612m |
| Dec 31 2020 | n/a | n/a | ₹589m |
| Sep 30 2020 | n/a | n/a | ₹474m |
| Jun 30 2020 | n/a | n/a | ₹322m |
| Mar 31 2020 | ₹13m | ₹11m | ₹251m |
| Dec 31 2019 | n/a | n/a | ₹314m |
| Sep 30 2019 | n/a | n/a | ₹274m |
| Jun 30 2019 | n/a | n/a | ₹257m |
| Mar 31 2019 | ₹13m | ₹11m | ₹250m |
| Dec 31 2018 | n/a | n/a | ₹158m |
| Sep 30 2018 | n/a | n/a | ₹168m |
| Jun 30 2018 | n/a | n/a | ₹201m |
| Mar 31 2018 | ₹13m | ₹11m | ₹200m |
Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Sambhu redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de Indian markt.
Compensatie versus inkomsten: De vergoeding van Sambhu is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Sambhu Sivalenka (50 yo)
25.8yrs
Tenure
₹12,759,000
Compensatie
Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Executive Chairman since February 13, 2012. He has been Director...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman & MD | 25.8yrs | ₹12.76m | 13.94% ₹ 2.9b | |
| Non-Executive Independent Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 3.5yrs | ₹1.95m | geen gegevens | |
| Non-Executive Non Independent Director | 1.4yrs | ₹1.12m | 7.76% ₹ 1.6b | |
| Non-Executive & Non Independent Director | 9.5yrs | ₹1.50m | 0.12% ₹ 25.6m | |
| Non-Executive Independent Director | 3.4yrs | ₹2.07m | geen gegevens | |
| Additional Non-Executive Independent Director | 2.3yrs | ₹1.49m | geen gegevens |
3.4yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van AMRUTANJAN wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).